Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007217
Filing Date
2022-05-05
Accepted
2022-05-05 07:00:40
Documents
56
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q elev-20220331x10q.htm   iXBRL 10-Q 1512227
2 EX-31.1 elev-20220331xex31d1.htm EX-31.1 10998
3 EX-31.2 elev-20220331xex31d2.htm EX-31.2 10890
4 EX-32 elev-20220331xex32.htm EX-32 7538
  Complete submission text file 0001558370-22-007217.txt   5123831

Data Files

Seq Description Document Type Size
5 EX-101.SCH elev-20220331.xsd EX-101.SCH 30748
6 EX-101.CAL elev-20220331_cal.xml EX-101.CAL 28670
7 EX-101.DEF elev-20220331_def.xml EX-101.DEF 112900
8 EX-101.LAB elev-20220331_lab.xml EX-101.LAB 322043
9 EX-101.PRE elev-20220331_pre.xml EX-101.PRE 235355
50 EXTRACTED XBRL INSTANCE DOCUMENT elev-20220331x10q_htm.xml XML 726625
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40523 | Film No.: 22893953
SIC: 2836 Biological Products, (No Diagnostic Substances)